Photo from wikipedia
Key Points Question What is the association between the use of 2 oral antivirals, molnupiravir and nirmatrelvir/ritonavir, and the risk of hospitalization and inpatient disease progression among patients with COVID-19… Click to show full abstract
Key Points Question What is the association between the use of 2 oral antivirals, molnupiravir and nirmatrelvir/ritonavir, and the risk of hospitalization and inpatient disease progression among patients with COVID-19 living in nursing homes? Findings In this cohort study of 14 617 patients, both molnupiravir and nirmatrelvir/ritonavir treatment were associated with a lower risk of hospitalization and a lower risk of inpatient disease progression. Meaning These findings suggest that the use of oral antivirals to treat COVID-19 may benefit older patients living in nursing homes by decreasing risks of hospitalization and inpatient disease progression.
Journal Title: JAMA Network Open
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!